Get the Stockscreener App
5.83
2.01%
0.115
Pre-market:
5.83
Imagenebio Inc stock is traded at $5.83, with a volume of 33,741.
It is up +2.01% in the last 24 hours and up +17.30% over the past month.
ImageneBio Inc is a clinical-stage biopharmaceutical company developing therapeutics for patients with immunological, autoimmune and inflammatory diseases. The company's flagship asset, IMG-007, is a non-depleting anti-OX40 monoclonal antibody that binds specifically to OX40 receptor on activated T cells to block receptor binding to OX40 ligand (OX40L). IMG-007 is being developed to potentially treat multiple autoimmune and inflammatory diseases and disorders. The company operates in a single segment.
See More
Previous Close:
$5.715
Open:
$5.71
24h Volume:
33,741
Relative Volume:
0.10
Market Cap:
$65.76M
Revenue:
$3.50M
Net Income/Loss:
$-43.07M
P/E Ratio:
-0.9033
EPS:
-6.4543
Net Cash Flow:
$-47.84M
1W Performance:
+1.39%
1M Performance:
+17.30%
6M Performance:
-29.08%
1Y Performance:
+0.00%
1-Day Range:
$5.5301
$5.93
1-Week Range:
$5.4953
$6.2146
52-Week Range:
$3.94
$17.96
Imagenebio Inc Stock (IMA) Company Profile
Name
Imagenebio Inc
Sector
Industry
Phone
857-343-8292
Address
12526 HIGH BLUFF DRIVE, SAN DIEGO
Compare IMA vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IMA
Imagenebio Inc
|
5.83 | 65.76M | 3.50M | -43.07M | -47.84M | -6.4543 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Imagenebio Inc Stock (IMA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-25-25 | Resumed | Wedbush | Underperform |
| Oct-24-25 | Initiated | Leerink Partners | Outperform |
Imagenebio Inc Stock (IMA) Latest News
IMA stock surges 24%, breaks 50-DMA for first time since February – what's driving the rally? - MSN
IMA SEC FilingsImageneBio 10-K, 10-Q, 8-K Forms - Stock Titan
IMA Price Today: ImageneBio, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
ImageneBio (NASDAQ: IMA) plans 2026 virtual meeting and equity plan vote - Stock Titan
OrbiMed adds pre-funded warrants in ImageneBio (IMA) 2026 PIPE - Stock Titan
IMA (ImageneBio) shares rise 2.42% after posting a narrower than expected Q4 2025 loss.Shared Buy Zones - Newser
ImageneBio $30 million private placement ignites stock - MSN
Short Interest in ImageneBio, Inc. (NASDAQ:IMA) Increases By 51.7% - MarketBeat
ImageneBio stock jumps on $30M financing - MSN
ImageneBio Inc (IMA) Competitors - Meyka
Trails Edge and Ortav Yehudai disclose 9.9% stake in ImageneBio (IMA) - Stock Titan
Omega Fund (IMA) discloses 8.4% ImageneBio ownership built via PIPE deals - Stock Titan
ImageneBio (IMA) accounting officer details RSU and option holdings in Form 3 - Stock Titan
IMA Stock Surges 24%, Breaks 50-DMA For First Time Since February – What's Driving The Rally? - Stocktwits
ImageneBio Completes $30 Million Private Placement to Advance Clinical Programs - Global Legal Chronicle
ImageneBio (IMA) director Su Wei-guo files insider report with no trades - Stock Titan
OrbiMed funds linked to ImageneBio (IMA) director buy 721,292 pre-funded warrants - Stock Titan
OrbiMed funds buy 721,292 ImageneBio (IMA) pre-funded warrants - Stock Titan
12 Health Care Stocks Moving In Monday's Intraday Session - Sahm
ImageneBio $30 Million Private Placement Ignites Stock - Sahm
Morning Market Movers: AVNS, SANA, CRDO, BE See Big Swings - RTTNews
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
ImageneBio raises $30M to advance alopecia, dermatitis drug By Investing.com - Investing.com Australia
ABDE Stock Poised For Best Rally In Over A Year — What’s Michael Burry Got To Do With It? - Stocktwits
ENDRA Life Sciences (NASDAQ: NDRA) Targets Billions With TAEUS Registered Liver Imaging Technology - openPR.com
ENDRA Life Sciences (NASDAQ: NDRA) Targets Billions With TAEUS® Liver Imaging Technology - Carroll County Mirror-Democrat
ImageneBio, Inc. Enters Securities Purchase Agreement for Private Placement to Support Drug Development (April 2026) - Minichart
IMA Stock Holds Support As Traders Track Cash-Fueled Runway - StocksToTrade
IMA Stock Holds Range As Traders Weigh Cash Burn - timothysykes.com
Morning Market Movers: ALLO, RECT, RVMD, SKYQ See Big Swings - RTTNews
ImageneBio (NASDAQ: IMA) registers 2,508,337 shares; $30M warrant placement - Stock Titan
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Imagenebio Inc Stock (IMA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.14%
0.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):